Amphastar Pharmaceuticals (AMPH) Income from Non-Controlling Interests (2018 - 2021)

Amphastar Pharmaceuticals' Income from Non-Controlling Interests history runs 4 years deep, the most recent figure standing at -$2.4 million for Q4 2021.

• In Q4 2021, Income from Non-Controlling Interests fell 592.72% year-over-year to -$2.4 million; the TTM figure through Dec 2021 stood at -$731000.0 (down 124.24% YoY), while the FY2021 annual figure was -$1.2 million, down 287.25% from the prior year.
• Income from Non-Controlling Interests was -$2.4 million for Q4 2021 at Amphastar Pharmaceuticals, down from $1.4 million in the prior quarter.
• In the past five years, Income from Non-Controlling Interests ranged from a high of $6.6 million in Q4 2019 to a low of -$2.4 million in Q4 2021.
• Historically, Income from Non-Controlling Interests has averaged $958500.0 across 4 years, with a median of $870500.0 in 2019.
• The sharpest annual moves came in 2020 and 2021: Income from Non-Controlling Interests soared 368.1% in 2020, then tumbled 592.72% in 2021.
• A 4-year view of Income from Non-Controlling Interests shows it stood at $1.7 million in 2018, then jumped by 292.27% to $6.6 million in 2019, then plunged by 92.77% to $481000.0 in 2020, then sank by 592.72% to -$2.4 million in 2021.
• The last three Income from Non-Controlling Interests figures came in at -$2.4 million (Q4 2021), $1.4 million (Q3 2021), and -$855000.0 (Q2 2021), per Business Quant data.